Glaxosmithkline | GSK - 流动资产



金融业
股票价格
GBP
资产
GBP 62.87B
现金及等价物
GBP 3.44B
销售成本
GBP 1.88B
流动资产
GBP 17.76B
流动负债
GBP 22.43B
债务
GBP 19.06B
股息收益率
GBP 4.47
EBIT
GBP 2.31B
EBITDA
GBP 2.77B
员工
GBP 69.4K
EPS每股收益
GBP 0.62
股本和储备
GBP 17.42B
销售毛利
GBP 5.75B
债务利息支出
GBP 192.73M
利息收入
GBP 22M
贷款资金
GBP 18.53B
市值
GBP 110.5B
净收入
GBP 1.74B
营业费用
GBP 5.34B
营业利润
GBP 2.29B
普通股股本
GBP 4.05B
PE价格收益
15.09
税前利润
GBP 2.14B
销售收入
GBP 10.09B
销售和管理费用
GBP 2.12B
股票
GBP 6.16B
贸易债权人
GBP 14.34B
应收帐款人
GBP 10.49B


流动资产 更改 日
AbbVie USD 33.53B 4.47B 2026-03
Amgen USD 31.48B 2.42B 2026-03
AstraZeneca USD 29.61B 890M 2026-03
Aurora Cannabis CAD 397.45M 48.38M 2026-03
Bausch Health Companies USD 5.98B 179M 2026-03
Bristol-Myers Squibb USD 27.21B 2.18B 2026-03
Canopy Growth CAD 529.47M 4.8M 2026-03
Corcept Therapeutics USD 426.03M 59.43M 2026-03
Drreddys Laboratories INR 301.98B 298.66B 2026-03
Eli Lilly USD 54.84B 794M 2026-03
GlaxoSmithKline GBP 17.76B 251M 2026-03
Glaxosmithkline GBP 17.76B 5.83B 2026-03
J&J USD 59.17B 3.55B 2026-03
Merck USD 35.02B 8.5B 2026-03
Novartis USD 26.61B 3.85B 2026-03
Pacira USD 514.96M 33.01M 2026-03
Perrigo USD 2.71B 85M 2026-03
Pfizer USD 42.82B 76M 2026-03
Phibro Animal Health USD 894.07M 31.88M 2026-03
Prestige Brands USD 431.48M 1.94M 2026-03
Roche Holding CHF 38.73B 3.03B 2025-12
Sanofi EUR 30.16B 789M 2026-03
Supernus Pharmaceuticals USD 731.58M 87.4M 2026-03
Takeda JPY 3.09T 25.94B 2026-03
Teva Pharmaceutical Industries USD 13.71B 236M 2026-03
Zoetis USD 6.47B 294M 2026-03